AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06331845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: a dose of 1-1.25 g/m2 twice daily in in 2 weeks for one cycle
Study NCT06331845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: 200 mg on Day 1
Study NCT05441306 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Personal Health Library (PerHL) + MyChart
Description: Participants randomized to the PerHL arm will have access to PerHL + the standard of care patient portal (Epic®MyChart).
Study NCT05441306 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Epic®MyChart
Description: Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart).
Study NCT06024733 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sevoflurane
Description: patient recieve propofol for induction and sevoflurane for maintenance
Study NCT06024733 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Target Controlled Infusion
Description: target controlled infusion of propofol
Study NCT06024733 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Target Controlled Infusion and lidocaine
Description: patients will receive total intravenous anesthesia with propofol Target Controlled Infusion. At the induction of anesthesia, the patients will receive a bolus of lidocaine 1% 1.5 mg/kg and a continuous infusion of lidocaine 1% 2 mg/kg/h will be associated throughout the procedure.
Study NCT05983887 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Climbing
Description: The protocol consists of using an in-door climbing wall as an complementary therapeutic intervention model.
Study NCT06072430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VBI-S
Description: VBI-S is made of small particles of specific lipids called micelles and liposomes for the treatment of hypotension.
Study NCT05386628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy
Description: A basic physiotherapy program consisting of shoulder exercises will be applied to the participants.~content of the physiotherapy program~* Shoulder passive/active abduction, flexion, internal and external rotation exercises~* Posture exercises~* Neck stretching exercises~* Pectoralis major stretching exercises~* Shoulder capsule stretching exercises~* Scapular Mobilization exercises
Study NCT06283251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PediRISE Resource Program
Description: A centrally administered, income-poverty targeted intervention that includes twice-monthly direct provision of unrestricted cash transfers along with benefits counseling to mitigate the risk of loss of means-tested benefits. Funds will be dispersed to families via provided debit card or through personal banking, PayPal, or Venmo.
Study NCT05013528 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bal-A-Vis-X training
Description: Bal-A-Vis-X training Performed thrice a week for 10 minutes after baseline assessment Standard Physical therapy treatment along with following exercises.~1. ball Rectangle~2. ball rectangle and 2 ball drop/pass/catch two-foot jumping forward, tandem walking on ground and tandem walking on the balance beam. .
Study NCT05013528 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bal-A-Vis-X training
Description: Bal-A-Vis-X training Performed thrice a week for 10 minutes after baseline assessment Standard Physical therapy treatment along with following exercises.~1. ball Rectangle~2. ball rectangle and 2 ball drop/pass/catch two-foot jumping forward, tandem walking on ground and tandem walking on the balance beam. .
Study NCT05013528 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic Training Group
Description: Aerobic training group performed exercises thrice a week for 10 minutes after baseline assessment.~Standard Physical therapy treatment along with aerobic training as Running is performed
Study NCT05013528 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Training Group
Description: Aerobic training group performed exercises thrice a week for 10 minutes after baseline assessment.~Standard Physical therapy treatment along with aerobic training as Running is performed
Study NCT04698408 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high-protein, carbohydrate-reduced diet
Description: the high-protein, carbohydrate-reduced diet will consist of 1.2-1.4 g/kg/d protein, 26-20en% carbohydrates and +/- 50en% fatty acids, with mainly unsaturated fatty acids. This diet consist of mainly unprocessed, fresh nutrient-dense food-products. Ultra-processed foods and alcoholic beverages will be totally avoided. Salt consumption will not exceed 5-6 g/d. The diet is ad libitum and caloric restriction will not be applied. The diet will be followed for 6 weeks.
Study NCT04698408 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dutch Nutritional Guidelines
Description: the diet according to the Dutch Nutritional Guidelines will consist of a protein intake of 0.8-1.0 g/kg/d and 50-60en% carbohydrates, and +/-30en% fatty acids, with restriction of saturated fatty acids \<10en%. This diet consist of mainly unprocessed, fresh nutrient-dense food-products. Ultra-processed foods and alcoholic beverages will be totally avoided. Salt consumption will not exceed 5-6 g/d. The diet is ad libitum and caloric restriction will not be applied. The diet will be followed for 6 weeks.
Study NCT05126095 — intervention group
Intervention type: RADIATION
Intervention: Radical radiotherapy
Description: Intensity-modulated radiation therapy (IMRT)
Study NCT05010681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab will be administered at 200 mg i.v. every 3 weeks until documented disease progression, development of unacceptable toxicity, participant request, or withdrawal of consent.
Study NCT05010681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib will be administered (bodyweight ≥ 60 kg, 12 mg; \< 60 kg, 8 mg) orally daily every 3 weeks until documented disease progression, development of unacceptable toxicity, participant request, or withdrawal of consent.
Study NCT05386628 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physiotherapy
Description: A basic physiotherapy program consisting of shoulder exercises will be applied to the participants.~content of the physiotherapy program~* Shoulder passive/active abduction, flexion, internal and external rotation exercises~* Posture exercises~* Neck stretching exercises~* Pectoralis major stretching exercises~* Shoulder capsule stretching exercises~* Scapular Mobilization exercises
Study NCT05386628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage
Description: manual lymph drainage is a manual technique that is applied to the lymphatic system with a pressure of 40-50 mmHg and increases the working speed of lymphatic nodules/collectors. Manual lymph drainage will be made to the anterior axillar-axillar, posterior axillar-axillar and axilla-inguinal anastomosis collectors and the arm region (up to the elbow) lymph collectors.
Study NCT05386628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial relasing
Description: it will be done with the thumb or 3rd finger from the acu points of the superficial arm-anterior myofascial chain. 6-8 seconds with thumb to these points. pressure will be applied and vibration will be given clockwise.
Study NCT04862195 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Attune™
Description: Software as a medical device
Study NCT04862195 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerena™
Description: Software as a medical device
Study NCT06260527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARTS-011
Description: Single ascending dose (SAD): 3mg, 10mg, 20mg, 40mg, and 60mg. Multiple ascending dose (MAD): 10mg QD, 20mg QD, and 40mg QD X 7 days. Food effect study: single dose of ARTS-011 under the fasting and high-fat meal.
Study NCT05252520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-77474462
Description: JNJ-77474462 will be administered subcutaneously.
Study NCT06260527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Multiple ascending dose (MAD): 10mg QD, 20mg QD, and 40mg QD X 7 days. Multiple ascending dose (MAD): 10mg QD, 20mg QD, and 40mg QD X 7 days.
Study NCT05892081 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Colloidal oatmeal
Description: The colloid oatmeal had the following component: Colloidal Oat (5gm), stearic acid 5, cretoctryl alcohol 2.5, cetyl alcohol 2.5, koh 02, potassium sorbate 1gm, paraffin oil 5ml, and soft paraffin 10gm
Study NCT05892081 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cold cream
Description: It is composed of stearic acid 5, cretoctryl alcohol 2.5, cetyl alcohol 2.5, koh 02, potassium sorbate 1gm, paraffin oil 5ml, and soft paraffin 10gm
Study NCT04516902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lysergic Acid Diethylamide
Description: A moderate dose of 100 μg LSD will be administered.
Study NCT04516902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3,4-methylenedioxymethamphetamine
Description: A moderate dose of 100 mg MDMA will be administered.
Study NCT04516902 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LSD Placebo
Description: Pure alcohol instead of an alcoholic solution containing LSD
Study NCT04516902 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: LSD Placebo
Description: Pure alcohol instead of an alcoholic solution containing LSD
Study NCT04516902 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MDMA Placebo
Description: Mannitol capsules instead of capsules containing MDMA
Study NCT04516902 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: MDMA Placebo
Description: Mannitol capsules instead of capsules containing MDMA
Study NCT05910593 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Dexterity Assessment Tool
Description: Measures finger dexterity using pressure sensor pads.
Study NCT06480045 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Performed PECS II block with AI integrated USG
Description: A 4-year anesthesiology resident, under the supervision of two senior anesthesiologists, performed a PECS II block with AI-integrated USG.
Study NCT06480045 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Performed PECS II block with conventional USG
Description: A 4-year anesthesiology resident, under the supervision of two senior anesthesiologists, performed a PECS II block with conventional USG.
Study NCT04573777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Repatha
Description: 140 MG in 1 ML Prefilled Syringe PCSK9 Inhibitor
Study NCT04462042 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Proton radiotherapy
Description: Proton radiotherapy
Study NCT04462042 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Photon radiotherapy
Description: Conventional photon radiotherapy
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1: How We Evolved - Threat, Impulse, and Soothing Systems
Description: The practice of Breath break with kindness will be applied for 5 minutes. Afterwards, 15 minutes of information on threats, impulses and soothing systems, A safe place application for 11 minutes, Courtesy meditation for 10 minutes. After each application, 10 minutes of feedback will be received from the participants.
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Session 2: Threat and Self-Compassion
Description: The practice of breathing with kindness will be done for 7 minutes. The practice of Building a compassionate relationship with resilience will be held for 12 minutes, and the practice of Kindness meditation: a benevolent will take place for 11 minutes. A hand over your heart application will be made for 3 minutes and A compassionate comrade application will be done for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Session 3: Unraveling the Knots of Desire and Patterns Agenda
Description: The practice of breathing with kindness will be done for 7 minutes. Building a compassionate relationship with desire 12 minutes, Guided meditation to discover the inner pattern 10 minutes and Courtesy meditation: a good friend 11 minutes. Except for the breath break with kindness application, 3 minutes of feedback will be received from the participants after each application
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Session 4: Internalizing compassion
Description: The pretend-to-be practice for the participants to observe themselves will be made for 10 minutes. The practice of internalizing compassion will be done for 7 minutes, kindness meditation: a neutral person practice for 10 minutes, and kindness towards your body for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Session 5: Me and others - Expanding the circle
Description: The a compassionate letter practice with the participants will continue for 15 minutes. meditation: the 'difficult' person 8 minutes, compassion and breathing: yourself 10 minutes and compassionate breathing: others 7 minutes. A compassionate break application is performed for 7 minutes.
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Session 6: Growing happiness
Description: The practice of Revisiting the good is carried out for 10 minutes with the participants. Forgive yourself, wish for forgiveness, forgive others, gratitude practices will be held for 5 minutes each and will take 20 minutes in total. Courtesy meditation: groups and all beings will be practiced for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Session 7: Weaving Wisdom and Compassion into Daily Life
Description: Participants will be given 10 minutes to choose a day in their life and allow a few minutes to pause mindfully. The practice of a breather for wise and compassionate action is 10 minutes, the practice of calmness meditation is 8 minutes, and the practice of sharing the joy meditation is 8 minutes. After each application, 3 minutes of feedback will be received from the participants.
Study NCT06449105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Session 8: Living with the Heart
Description: The participants are told about the applications they can apply for, where they need help to develop compassion towards self-healing skills, and the entire training will be evaluated for 20 minutes. The river of life application is carried out for 20 minutes. 10 minutes of feedback will be received after the application.
Study NCT05600712 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: REDAPT Sleeved Stem
Description: The REDAPT Sleeved Stem is designed to provide secondary proximal support to the distal fixation and enhance implant stability.
Study NCT05382325 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MK-1484
Description: Subcutaneous (SC) injection
Study NCT05382325 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intravenous (IV) infusion
Study NCT06323720 — intervention group
Intervention type: OTHER
Intervention: Quantitative Sensory Testing
Description: Assessment of the heat and cold pain thresholds, temporal summation, conditioned pain modulation, pressure pain thresholds, electrical pain thresholds, and withdrawal reflex.
Study NCT06260839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: magnetic resonance neurography
Description: preoperative magnetic resonance neurography and assisted design of surgical approach
Study NCT06260839 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: no magnetic resonance neurography
Description: Preoperative magnetic resonance neurography was not performed, and general minimally invasive surgery was performed
Study NCT04119908 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Sublingual videomicroscopy
Description: Measurement of sublingual capillary density by video microscopy
Study NCT04119908 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sublingual videomicroscopy
Description: Measurement of sublingual capillary density by video microscopy
Study NCT04119908 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: blood sample
Description: Collection of citrate tubes of 5 mL at baseline and at 36 months
Study NCT05739617 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comprehensive Respiratory Training Exercise Program
Description: This comprehensive respiratory training exercise program consists of four main components, including oropharyngeal muscle training, respiratory muscle training, aerobic exercise, and sleep hygiene education.
Study NCT05739617 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sleep hygiene education
Description: Sleep hygiene education
Study NCT04785885 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: iStat Handheld Blood Analyzer
Description: An easy-to-use blood analyzer that provides monitoring of heparin anticoagulation quickly for point-of-care testing. Testing will be done at baseline, 30s, 90s and 180s after heparin administration.
Study NCT04785885 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hemochron
Description: An easy-to-use blood analyzer that provides monitoring of heparin anticoagulation quickly for point-of-care testing. Testing will be done at baseline, 30s, 90s and 180s after heparin administration.
Study NCT05041543 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTX-101
Description: Eye drops, topical administration
Study NCT05041543 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo as eye drops
Study NCT05110586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrotherapy
Description: Applications will be applied for 4 weeks, 5 days a week
Study NCT04977505 — intervention group
Intervention type: DEVICE
Intervention: pushlock
Description: The surgery procedure was performed with pushlock for fixation
Study NCT04977505 — intervention group
Intervention type: DEVICE
Intervention: gryphon
Description: The surgery procedure was performed with Gryphon for fixation
Study NCT06509516 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified Sleeper-Stretch
Description: Self-administered stretch in which the individual remains side-lying on the upper limb to be stretched, keeping the scapula stabilized by his/her own weight, and rolls the trunk 20-30º posteriorly, maintaining a 90º flexion in the shoulder and elbow. Using the opposite hand over the forearm of the limb to be stretched, the individual passively brings the shoulder to maximum internal rotation.
Study NCT06211283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium valproate
Description: fasted
Study NCT06211283 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium valproate
Description: fasted
Study NCT06211283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium valproate
Description: fed
Study NCT06211283 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium valproate
Description: fed
Study NCT05047393 — intervention group
Intervention type: OTHER
Intervention: Current blood vitamin D level and painDetect questionairre score will be detected
Description: PainDETECT neuropathic pain questionnaire will be used to evaluate the presence of nociceptive, mixed and neuropathic pain in patients. Patients with a total questionnaire score of 12 or less are considered nociceptive pain without a neuropathic pain component. If the total score is in the range of 13-18, the result is uncertain, but it is accepted that the neuropathic component can be found in the mixed type, and in the scores of 19 and above, it is accepted that the neuropathic pain component is present. Patients with previously obtained and finalized vitamin D levels \< 20 ng/mL, 20-30 ng/mL, and ˃30 ng/mL will be grouped as deficiency, insufficiency and normal, respectively.
Study NCT05684731 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KM1
Description: Administer via intraperitoneal infusion for 3 or 6 doses Q3D.
Study NCT05684731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Physician's Choice of carboplatin (preferred) or cisplatin，gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin，with or without bevacizumab.~Administer beginning in Week 5 or Week 6.
Study NCT05886517 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transfemoral transcatheter aortic valve implementation
Description: ranscatheter aortic valve implantation, a percutaneous treatment for severe aortic valve stenosis, is increasingly performed worldwide. The pacemaker should be able to perform overdrive pacing which is essential to reduce cardiac output and transvalvular blood flow which are critical during balloon aortic valvuloplasty and valve deployment of the balloon- expandable valve. Minor adjustment may be needed for ideal positioning, but importantly this has to be done before valve implantation
Study NCT05001503 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stability UO
Description: STABILITY UO is a standalone software, based on a Bayesian model, which quantifies the risk of an individual patient developing severe oliguria (0.3mg/kg/hr for 6 hours). The model identifies at risk patients by predicting future urine output, using only previously recorded urine output values for that individual, allowing clinicians to see the predicted risk of a patient developing severe oliguria in real time.